[Indication for the use of glycodiazine (Redul) as an oral antidiabetic].
D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*
D007004:Hypoglycemic Agents
Indikation für Glykodiacin (Redul) als orales Antidiabetikum.